MedPath

Effect of Squill Oxymel in Treatment of Knee Arthrosis

Phase 2
Conditions
knee osteoarthritis.
Gonarthrosis
Registration Number
IRCT2015101124474N1
Lead Sponsor
Traditional Medicine College of Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Inclusion Criteria:
Age 40 to 80 years old that fill clinical and radiological criteria of ACR. after drug wash out,with VAS>40mm.
clinical and radiological criteria of ACR: knee pain + osteophite in radiography + at least 1 of 3 below criteria: age up 50 years old; morning stiffness less than 30 minutes; crepitation of knee.

Exclusion Criteria

history of rheumatoid arthritis and gout;
history of knee surgery;
patients with severe cardiovascular disease, including heart failure, advanced Class 3 and 4, sick sinus syndrome (SSS), 3rd degree atrioventricular block, Wolff Parkinson's White syndrome (WPW), ventricular tachycardia (VT), hypertrophic cardiomyopathy, aortic thoracic aneurysm;
proven malignancies;
GI bleeding(stomach bleeding);
severe liver disease(esophageal varices and bleeding, encephalopathy, ascites);
patients with Symptomatic gallstone(in history);
severe renal disease(creatinine greater than 3mg / dl);
joint injection of corticosteroids in the past three months;
received oral corticosteroids in the past 4 weeks;
oral or injectable NSAID in last seven days;
received chondrotin sulfate or glucosamine, warfarin, clopidogrel, digitalis, capsaicin, quinidine, laxatives or any other drugs, according to pharmacologists opinion;
pregnancy and Breast-feeding.
Exit criteria during study:
Not wanting to continue taking the drug by the patient for any reason;
Allergy symptoms or complications to acetaminophen or squill oxymel;
Any clinical condition that need to change a patient's treatment regimen.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath